R

Romosozumab

Chemical compound

Romosozumab, sold under the brand name Evenity ( ih-VENN-ih-tee or with the pin-pen merger, ih-VINN-ih-tee), is a medication used to treat osteoporosis. It has been found to decrease the risk of fractures of the spine. Common side effects include headache, joint pain, and injection site reactions including pain.

Nº Q7363297 ★

Common · Knowledge

Romosozumab

Chemical compound

Romosozumab, sold under the brand name Evenity ( ih-VENN-ih-tee or with the pin-pen merger, ih-VINN-ih-tee), is a medication used to treat osteoporosis. It has been found to decrease the risk of fractures of the spine. Common side effects include headache, joint pain, and injection site reactions including pain.

Last price

—

Floor price

—

7-day median

—

30-day sales

0

30-day range

—

In circulation

0

Price history

Show table
Datemedian LowHighsales

Sales history

Last sale
—
30-day average
—
30-day low
—
30-day high
—
Sales 7d
0
Sales 30d
0

No sales yet.

Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.

From Wikipedia

Romosozumab, sold under the brand name Evenity ( ih-VENN-ih-tee or with the pin-pen merger, ih-VINN-ih-tee), is a medication used to treat osteoporosis. It has been found to decrease the risk of fractures of the spine. Common side effects include headache, joint pain, and injection site reactions including pain. It may increase the risk of heart attacks, strokes, and deaths from cardiovascular disease. It is a humanized monoclonal antibody that targets sclerostin. Research shows the drug increases bone formation and decreases bone resorption in postmenopausal women with low bone density. Romosozumab was approved for medical use in Japan, the United States and the European Union in 2019. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.

Text: Wikipédia, CC BY-SA 4.0. ·

Related cards

View card

Confirmation